Education
About Us
Working with TipRanks
Follow Us
Eckert & Ziegler Strahlen und Medizintechnik (DE:EUZ)
:EUZ
RESEARCH TOOLSreports
Total Valuation
Eckert & Ziegler Strahlen und Medizintechnik has a market cap or net worth of €1.38B. The enterprise value is ―.
Market Cap€1.38B
Enterprise Value―
Share Statistics
Eckert & Ziegler Strahlen und Medizintechnik has 21,171,932 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,171,932
Owned by Insiders31.13%
Owned by Institutions―
Financial Efficiency
Eckert & Ziegler Strahlen und Medizintechnik’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 9.29%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)9.29%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee226.81K
Profits Per Employee28.09K
Employee Count1,085
Asset Turnover0.56
Inventory Turnover3.25
Valuation Ratios
The current PE Ratio of Eckert & Ziegler Strahlen und Medizintechnik is 32.68. Eckert & Ziegler Strahlen und Medizintechnik’s PEG ratio is -3.43.
PE Ratio32.68
PS Ratio0.00
PB Ratio4.77
Price to Fair Value3.87
Price to FCF27.05
Price to Operating Cash Flow18.90
PEG Ratio-3.43
Income Statement
In the last 12 months, Eckert & Ziegler Strahlen und Medizintechnik had revenue of 246.09M and earned 26.30M in profits. Earnings per share was 1.26.
Revenue246.09M
Gross Profit116.34M
Operating Income47.00M
Pretax Income42.31M
Net Income26.30M
EBITDA59.67M
Earnings Per Share (EPS)1.26
Cash Flow
In the last 12 months, operating cash flow was 62.76M and capital expenditures -18.90M, giving a free cash flow of 43.86M billion.
Operating Cash Flow62.76M
Free Cash Flow43.86M
Free Cash Flow per Share2.07
Dividends & Yields
Eckert & Ziegler Strahlen und Medizintechnik pays an annual dividend of €5.149, resulting in a dividend yield of 0.07%
Dividend Per Share€5.149
Dividend Yield0.07%
Payout Ratio3.02%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.24
52-Week Price Change57.88%
50-Day Moving Average58.40
200-Day Moving Average49.60
Relative Strength Index (RSI)62.65
Average Volume (3m)31.30K
Important Dates
Eckert & Ziegler Strahlen und Medizintechnik upcoming earnings date is Aug 8, 2025, TBA Not Confirmed.
Last Earnings DateMay 13, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend DateJun 19, 2025
Financial Position
Eckert & Ziegler Strahlen und Medizintechnik as a current ratio of 2.79, with Debt / Equity ratio of 20.90%
Current Ratio2.79
Quick Ratio2.31
Debt to Market Cap0.03
Net Debt to EBITDA-0.20
Interest Coverage Ratio11.77
Taxes
In the past 12 months, Eckert & Ziegler Strahlen und Medizintechnik has paid 11.82M in taxes.
Income Tax11.82M
Effective Tax Rate0.28
Enterprise Valuation
Eckert & Ziegler Strahlen und Medizintechnik EV to EBITDA ratio is 14.21, with an EV/FCF ratio of 40.14.
EV to Sales3.45
EV to EBITDA14.21
EV to Free Cash Flow40.14
EV to Operating Cash Flow18.06
Balance Sheet
Eckert & Ziegler Strahlen und Medizintechnik has €97.63M in cash and marketable securities with €51.92M in debt, giving a net cash position of -€45.71M billion.
Cash & Marketable Securities€97.63M
Total Debt€51.92M
Net Cash-€45.71M
Net Cash Per Share-€2.16
Tangible Book Value Per Share€8.60
Margins
Gross margin is 48.08%, with operating margin of 19.10%, and net profit margin of 10.69%.
Gross Margin48.08%
Operating Margin19.10%
Pretax Margin17.19%
Net Profit Margin10.69%
EBITDA Margin24.25%
EBIT Margin18.81%
Analyst Forecast
The average price target for Eckert & Ziegler Strahlen und Medizintechnik is €67.55, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€67.55
Price Target Upside1.20% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast15.89%
EPS Growth Forecast14.62%